Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...